A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With DocetaxelPierre Maison‐Blanche, E. Magherini, Sanjiv S. Agarwala et al.|Journal of Cardiovascular Pharmacology|2013Cited by 5
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancerFrancesco Grossi, Enzo Galligioni, Filippo de Marinis et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 3